Company Overview

PALISADE BIO, INC.

PALI
Annual
Revenue vs. Cost of Revenue
Revenue Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses Operating Income
Net Income
Net Income
Revenue
—M
2025 FY
Net Income
-17M
2025 FY
Shares Outstanding
56M
2025 FY
EPS
-0.3USD
2025 FY
Company Information
SIC Code
2836
CIK Code
1357459
Exchange
Nasdaq
Location
US